Levi J. Beverly
Impact in
- Cancer Research top 5%
- Hematology top 5%
- Acute Myeloid Leukemia Research
Papers in
-
- Chemotherapy-induced organ toxicity mitigation 11
- Co-authors
- Anthony J. CapobiancoLeah J. SiskindHarold VarmusParag P. ShahKatrina PodsypaninaGauri A. PatwardhanDean W. FelsherMartin Jechlinger
- Journals
- American Journal of Physiology-Renal Physiology (8 papers)Journal of Cellular Biochemistry (4 papers)Scientific Reports (3 papers)Journal of Biological Chemistry (3 papers)Oncotarget (3 papers)
- Partner nations
- United StatesCanadaIndia
In The Last Decade
Levi J. Beverly
63 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 104
- Cancer Research 403
- Hematology 297
- Molecular Biology 1.7k
- Oncology 601
- Cell Biology 277
Countries citing papers authored by Levi J. Beverly
This map shows the geographic impact of Levi J. Beverly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levi J. Beverly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levi J. Beverly more than expected).
Fields of papers citing papers by Levi J. Beverly
This network shows the impact of papers produced by Levi J. Beverly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levi J. Beverly. The network helps show where Levi J. Beverly may publish in the future.
Co-authors
The 25 scholars most cited alongside Levi J. Beverly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 10 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2019 | 16 | |
| 5 | 2019 | 73 | |
| 6 | 2019 | 17 | |
| 7 | 2018 | 14 | |
| 8 | 2018 | 6 | |
| 9 | 2017 | 41 | |
| 10 | 2017 | 1 | |
| 11 | 2015 | 49 | |
| 12 | 2015 | 107 | |
| 13 | 2014 | 53 | |
| 14 | 2013 | 155 | |
| 15 | 2013 | 17 | |
| 16 | 2009 | 94 | |
| 17 | 2008 | 238 | |
| 18 | 2005 | 126 | |
| 19 | 2003 | 99 | |
| 20 | 2003 | 114 |
About Levi J. Beverly
Levi J. Beverly is a scholar working on Hematology, Pathology and Forensic Medicine, Cancer Research, Molecular Biology and Oncology, having authored 65 papers that have together received 2.7k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (14 papers), Chemotherapy-induced organ toxicity mitigation (11 papers), Acute Lymphoblastic Leukemia research (9 papers), Cell death mechanisms and regulation (8 papers), Sphingolipid Metabolism and Signaling (7 papers), Cancer-related gene regulation (7 papers), RNA modifications and cancer (7 papers) and Cancer Cells and Metastasis (6 papers). The work is most often cited by research in Cancer Research (403 citations), Hematology (297 citations), Molecular Biology (1.7k citations), Oncology (601 citations) and Cell Biology (277 citations). Levi J. Beverly has collaborated with scholars based in United States, Canada and India. Frequent co-authors include Anthony J. Capobianco, Leah J. Siskind, Harold Varmus, Parag P. Shah, Katrina Podsypanina, Gauri A. Patwardhan, Dean W. Felsher, Martin Jechlinger, Dolores Hambardzumyan and Mark A. Doll. Their work appears in journals such as American Journal of Physiology-Renal Physiology, Journal of Cellular Biochemistry, Scientific Reports, Journal of Biological Chemistry and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.